Ethitek Pharmaceuticals

Ethitek Pharmaceuticals was a specialty pharmaceutical company based in Skokie, Illinois, that focused on the development and commercialization of injectable medications for the hospital and critical care markets. The company's primary product was Etomidate, a short-acting intravenous anesthetic agent used for the induction of general anesthesia and sedation during medical procedures. Ethitek established a significant presence in the U.S. generic injectable market by providing high-quality, essential medications to healthcare providers. In July 2017, Piramal Critical Care, a subsidiary of Piramal Enterprises, acquired the assets of Ethitek Pharmaceuticals to expand its anesthesia and critical care portfolio. This acquisition allowed Piramal to integrate Ethitek's established product line into its global distribution network.